Administration of glutamine after hemorrhagic shock restores cellular energy, reduces cell apoptosis and damage, and increases survival

Journal of Parenteral and Enteral Nutrition

Volumn 31, Issue 2, 2007, Pages 94-100

  Yang, Rongjie ^a   Lisa, Martin Hawver ^a   Woodall, Charles ^a   Thomas, Ann ^a   Qureshi, Nilofer ^b   Morrison, David ^b   Van Way, Charles ^a,b,c  

^a Departments of Surgery   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALANINE; CASPASE 3; CYTOCHROME C; GLUTAMINE; GLYCINE; PROTEIN BCL 2; RINGER LACTATE SOLUTION; XANTHINE; FREE RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL ENERGY; CONTROLLED STUDY; HEMORRHAGIC SHOCK; LIVER CYTOSOL; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; RAT; RESUSCITATION; SURVIVAL; ANIMAL; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER; METABOLISM; RANDOMIZATION; SPRAGUE DAWLEY RAT;

RATTUS;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; CASPASE 3; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROMES C; FREE RADICALS; GLUTAMINE; LIVER; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, HEMORRHAGIC; XANTHINE;

EID: 34247889980     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/014860710703100294     Document Type: Article

References (35)

1. Helling TS, Wogahn BM, Olson SA, Evans LS, Reddy BR, Van Way C. The effect of prostaglandin E1 on liver adenine nucleotides and cytoplasmic enzymes in a porcine model of normother-mic hepatic ischemia. Hepatology. 1995;22:1554-1559.
2. Van Way C, Dhar A, Reddy R, Evans L, Wogahn B, Helling TS. Changes in adenine nucleotides during hemorrhagic shock and reperfusion. J Surg Res. 1996;66:159-166.
3. Chaudry IH, Sayeed MM, Baue AE. Alterations in high-energy phosphates in hemorrhagic shock as related to tissue and organ function. Surgery. 1976;79:666-668.
4. Chang CG, Van Way CW 3rd, Dhar A, Helling T Jr, Hahri Y. The use of insulin and glucose during resuscitation from hemorrhagic shock increases hepatic ATP. J Surg Res. 2000;92:171-176.
5. Chaudry IH, Sayeed MM, Baue AE. Depletion and restoration of tissue ATP in hemorrhagic shock. Arch Surg. 1974;108:208-211.
6. Schloerb PR, Sieracki L, Botwin AJ, Winblad JM, Maguire MH. Intravenous adenosine triphosphate (ATP) in hemorrhagic shock in rats. Am J Physiol. 1981;9:R52-R60.
7. Van Way CW 3rd, Dhar A, Morrison DC, Longorio MA, Maxfield DM. Cellular energetics in hemorrhagic shock: restoring adenosine triphosphate to the cells. J Trauma. 2003;54(5 suppl):S169-S176.
8. Inoue I, Nagase H, Kishi K, Higuti T. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature. 1991;352:244-247.
9. Dhar A, Kujath S, Van Way CVV 3rd. Glutamine administration during total parenteral nutrition protects liver adenosine nucleotides during and after subsequent hemorrhagic shock. JPEN J Parenter Enteral Nutr. 2003;27:246-251.
10. Darlington DN, Gann DS. Adenosine stimulates NA/K ATPase and prolongs survival in hemorrhagic shock. J Trauma. 2005; 58:1-6.
11. Zager RA. Adenine nucleotide changes in kidney, liver, and small intestine during different forms of ischemic injury. Circ Res. 1991;68:185-196.
12. Van Way CW 3rd, Dhar A, Morrison D. Hemorrhagic shock: a new look at an old problem. Mo Med. 2003;100:518-523.
13. Oliveira PJ, Goncalves L, Monteiro P, Providencia LA, Moreno AJ. Are the antioxidant properties of carvedilol important for the protection of cardiac mitochondria? Curr Vasc Pharmacol. 2005; 3:147-158.
14. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001;50:537-546.
15. Foldes-Papp Z, Domej W, Demel U, Tilz GP. Oxidative stress caused by acute and chronic exposition to altitude. Wien Med Wochenschr. 2005;155:136-142.
16. Genesca M, Sola A, Miquel R, et al. Role of changes in tissular nucleotides on the development of apoptosis during ischemia/reperfusion in rat small bowel. Am J Pathol. 2002;161: 1839-1847.
17. Chopp M, Chan PH, Hsu CY, Cheung ME, Jacobs TP. DNA damage and repair in central nervous system injury: National Institute of Neurological Disorders and Stroke Workshop Summary. Stroke. 1996;27:363-369.
18. Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol. 2003;15:725-731.
19. Bossenmeyer-Pourie C, Koziel V, Daval JL. Effects of hypothermia on hypoxia-induced apoptosis in cultured neurons from developing rat forebrain: comparison with preconditioning. Pedi-atrRes. 2000;47:385-391.
20. Kunduzova OR, Escourrou G, De La Farge F, et al. Involvement of peripheral benzodiazepine receptor in the oxidative stress, death-signaling pathways, and renal injury induced by isch-emia-reperfusion. J Am Soc Nephrol. 2004;15:2152-2160.
21. Davidson MT, Deitch EA, Lu Q, et al. Trauma-hemorrhagic shock mesenteric lymph induces endothelial apoptosis that involves both caspase-dependent and caspase-independent mechanisms. Ann Surg. 2004;240:123-131.
22. Vats P, Mukherjee AK, Kumria MM, et al. Changes in the activity levels of glutamine synthetase, glutaminase and glycogen synthetase in rats subjected to hypoxic stress. Int J Biom-eteorol. 1999;42:205-209.
23. Oehler R, Roth E. Regulative capacity of glutamine. Curr Opin Clin Nutr Metab Care. 2003;6:277-282.
24. Goeters C, Wenn A, Mertes N, et al. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med. 2002;30:2153-2154.
25. Griffiths RD, Allen KD, Andrews FJ, Jones C. Infection, multiple organ failure, and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition. 2002;18:546-552.
26. Grimble RF. Immunohutrition. Curr Opin Gastroenterol. 2005; 21:216-222.
27. Mendez C, Jurkovich GJ, Garcia I, Davis D, Parker A, Maier RV. Effects of an immune-enhancing diet in critically injured patients. J Trauma. 1997;42:933-941.
28. Bistrian BR. Practical recommendations for immune-enhancing diets. J Nutr. 2004;134(10 suppl):2868S-2872S; discussion 2895S.
29. Yang R, Tan X, Thomas AM, et al. Alanine-glutamine dipeptide (AGD) inhibits expression of inflammation-related genes in hemorrhagic shock. JPEN J Parenter Enteral Nutr. 2007;31:32-36.
30. Singleton KD, Beckey VE, Wischmeyer PE. Glutamine prevents activation of NF-kappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock. 2005;24:583-589.
31. Sun S, Elwood J, Greene WC. Both amino- and carboxyl-termi-nal sequences within I kappa B alpha regulate its inducible degradation. Mol Cell Biol. 1996;16:1058-1065.
32. Qureshi N, Vogel SN, Van Way C 3rd, Papasian CJ, Qureshi AA, Morrison DC. The proteasome: a central regulator of inflammation and macrophage function. Immunol Res. 2005;31:243-260.
33. O'Connor S, Markovina S, Miyamoto S. Evidence for a phospho-rylation- independent role for Ser 32 and 36 in proteasome inhibitor-resistant (PIR) IkappaBalpha degradation in B cells. Exp Cell Res. 2005;307:15-25.
34. Ziegler TR, Ogden LG, Singleton KD, et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med. 2005:31;1079-1086.
35. Peng ZY, Hamiel CR, Banerjee A, Wischmeyer PE, Friese RS, Wischmeyer P. Glutamine attenuation of cell death and inducible nitric oxide synthase expression following inflammatory cytokine-induced injury is dependent on heat shock factor-1 expression. JPEN J Parenter Enteral Nutr. 2006;30:400-407.